Use of oral anticoagulation therapy in the first 3 months after the diagnosis of atrial fibrillation in Israel: a population ‐based study
ConclusionIn this real world, population ‐based cohort of patients with newly diagnosed AF, we found a lower than expected rate of OAC prescription within 3 months of diagnosis but an encouraging increase in OAC purchasing over time. Use of NOACs has risen exponentially in only a few years, accounting for a greater pool of AF patients be ing prescribed an OAC.This article is protected by copyright. All rights reserved.
Source: Journal of Cardiovascular Electrophysiology - Category: Cardiology Authors: Louise Kezerle,
Meytal Avgil Tsadok,
Adi Berliner Senderey,
Moshe Hoshen,
Maya Leventer ‐Roberts,
Orna Reges,
Morton Leibowitz,
Moti Haim Tags: ORIGINAL ARTICLE Source Type: research
More News: Atrial Fibrillation | Bleeding | Cardiology | Cardiovascular | Coumadin | Databases & Libraries | Electronic Medical Records (EMR) | Heart | History of Medicine | Ischemic Stroke | Israel Health | Middle East Health | Stroke | Study | Vitamin K | Vitamins | Warfarin | Women